Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Diebold Nixdorf Set to Join Russell 3000® Index
-
Fannie Mae Releases April 2024 Monthly Summary
-
Fusion Pharmaceuticals Shareholders Approve Acquisition by AstraZeneca
-
Nanalysis Announces First Quarter 2024 Results
-
ICF to Present at the William Blair 44th Annual Growth Stock Conference
-
Rollins to Present at Upcoming Investor Conferences
-
Carlyle Credit Income Fund Announces Second Quarter 2024 Financial Results
-
10x Genomics Launches 5,000-Plex Gene Panel for Xenium
-
Karyopharm to Participate at the Jefferies Global Healthcare Conference
-
AAR named to Newsweek's America's Greatest Workplaces for Diversity 2024
-
Yext to Announce First Quarter Fiscal Year 2025 Financial Results on June 10, 2024
-
Quantum Announces Timing for the Reporting of Financial Results and other Business Matters
-
MillerKnoll Schedules Fourth Quarter and Full Fiscal Year 2024 Conference Call and Webcast
-
Allurion to Participate in Two Upcoming Investor Conferences in June 2024
-
Yelp to Participate in the Baird Global Consumer, Technology & Services Conference
-
Rocket Companies CEO Varun Krishna to Present at Morgan Stanley U.S. Financials, Payments & CRE Conference
-
Senseonics Holdings, Inc. to Participate in the Sidoti Small Cap Conference
-
OneMedNet Inks Agreement with a Global Top-10 Medical Technology Company
-
Versus Systems Announces Cancellation of Special Meeting Scheduled for May 30, 2024
-
Cardiff Oncology to Present at the Jefferies Healthcare Conference
-
Singular Genomics to Present at the Goldman Sachs Global Healthcare Conference
-
TRxADE Health, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q
-
iLearningEngines to Present at the Stifel Cross Sector Insight Conference
-
Enliven Therapeutics to Present at Two Upcoming Investor Conferences
-
Post Holdings Reports Avian Influenza at Third-Party Contracted Facilities and Affirms Fiscal Year 2024 Adjusted EBITDA Outlook
-
nCino Reports First Quarter Fiscal Year 2025 Financial Results
-
Torrid Announces Reporting Date for First Quarter Fiscal 2024 Financial Results
-
Mister Car Wash Announces Participation in the William Blair 44th Annual Growth Stock Conference
-
Credo Technology Group Holding Ltd Reports Fourth Quarter and Fiscal Year 2024 Financial Results
-
Latham Group, Inc. to Participate at Upcoming Conferences
-
Standard Lithium to Attend Upcoming Industry Conferences
-
QIAGEN launches new library preparation kit, facilitating multiomic studies and advancing precision medicine
-
Definitive Healthcare to Present at the Stifel 2024 Cross Sector Insight Conference
-
Adaptive Biotechnologies to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
-
Mondelēz International to Participate at the Deutsche Bank Global Consumer Conference on June 4, 2024
-
Robinhood Markets, Inc. to Present at the Piper Sandler Global Exchange and Trading Conference on June 5, 2024
-
Immuneering to Present at the Jefferies Global Healthcare Conference
-
Nest Seekers International's Loy Carlos Launches Office of Global Wealth in Qatar
-
XS Financial Reports First Quarter 2024 Results
-
SchoolsFirst Federal Credit Union Announces Winners of 2024 Member Education Award Scholarships
-
Salesforce Announces First Quarter Fiscal 2025 Results
-
Okta Announces First Quarter Fiscal Year 2025 Financial Results
-
Neurocrine Biosciences to Participate at Investor Conferences in June
-
Atara Biotherapeutics Presents Preclinical Data on ATA3219, an Allogeneic CD19-Targeted CAR T Therapy for the Treatment of B-Cell Driven Autoimmune Diseases, at the ISCT 2024 Annual Meeting
-
Kezar Life Sciences to Participate in the Jefferies Global Healthcare Conference
-
GlycoMimetics to Host Key Opinion Leader Event to Review Comprehensive Results from Pivotal Phase 3 Study of Uproleselan in Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML) on June 4, 2024
-
Immunovant Provides Corporate Updates and Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2024
-
Clean Energy Special Situations Corp. Receives Notice from Nasdaq Regarding Suspension of Trading of Securities
-
Fate Therapeutics to Present at 2024 Jefferies Global Healthcare Conference
-
Additional Data Showing Acoramidis Increases Serum Transthyretin Which is Associated with Improved Cardiovascular Outcomes Presented at ISA from BridgeBio Pharma’s Phase 3 ATTRibute-CM Study in Tran
